We’ve recently updated our valuation analysis.

Chimera Investment Valuation

Is CIM undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CIM?

Other financial metrics that can be useful for relative valuation.

CIM key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDAn/a
PEG Ration/a

Price to Book Ratio vs Peers

How does CIM's PB Ratio compare to its peers?

The above table shows the PB ratio for CIM vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPBEstimated GrowthMarket Cap
Peer Average0.9x
PMT PennyMac Mortgage Investment Trust
0.9x101.7%US$1.4b
LADR Ladder Capital
0.9x-15.5%US$1.4b
BRSP BrightSpire Capital
0.7x-1.4%US$913.1m
TWO Two Harbors Investment
1x-30.3%US$1.4b
CIM Chimera Investment
0.6x95.3%US$1.6b

Price-To-Book vs Peers: CIM is good value based on its Price-To-Book Ratio (0.6x) compared to the peer average (0.9x).


Price to Earnings Ratio vs Industry

How does CIM's PE Ratio compare vs other companies in the US Mortgage REITs Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a26.6%
n/an/an/a

Price-To-Book vs Industry: CIM is good value based on its Price-To-Book Ratio (0.6x) compared to the US Mortgage REITs industry average (0.8x)


Price to Book Ratio vs Fair Ratio

What is CIM's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CIM PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio0.6x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate CIM's Price-To-Book Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of CIM when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CIM ($6.69) is trading above our estimate of fair value ($2.43)

Significantly Below Fair Value: CIM is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CIM forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$6.69
US$7.25
+8.4%
17.2%US$9.00US$5.50n/a4
Nov ’23US$6.78
US$7.25
+6.9%
17.2%US$9.00US$5.50n/a4
Oct ’23US$5.22
US$9.38
+79.6%
11.5%US$11.00US$8.00n/a4
Sep ’23US$8.24
US$9.38
+13.8%
11.5%US$11.00US$8.00n/a4
Aug ’23US$10.53
US$9.38
-11.0%
11.5%US$11.00US$8.00n/a4
Jul ’23US$9.04
US$10.94
+21.0%
7.3%US$12.00US$9.75n/a4
Jun ’23US$9.92
US$10.94
+10.3%
7.3%US$12.00US$9.75n/a4
May ’23US$10.02
US$12.13
+21.0%
14.4%US$15.00US$10.50n/a4
Apr ’23US$12.11
US$14.31
+18.2%
7.3%US$15.50US$12.75n/a4
Mar ’23US$11.92
US$14.31
+20.1%
7.3%US$15.50US$12.75n/a4
Feb ’23US$14.29
US$15.19
+6.3%
11.9%US$18.00US$13.25n/a4
Jan ’23US$15.08
US$14.63
-3.0%
18.0%US$18.00US$11.00n/a4
Dec ’22US$15.62
US$14.63
-6.4%
18.0%US$18.00US$11.00n/a4
Nov ’22US$15.80
US$13.56
-14.2%
14.9%US$16.00US$11.00US$6.784
Oct ’22US$15.02
US$13.44
-10.5%
14.4%US$16.00US$11.00US$5.224
Sep ’22US$15.32
US$13.44
-12.3%
14.4%US$16.00US$11.00US$8.244
Aug ’22US$14.72
US$12.94
-12.1%
10.8%US$14.50US$11.00US$10.534
Jul ’22US$15.10
US$12.94
-14.3%
10.8%US$14.50US$11.00US$9.044
Jun ’22US$14.36
US$12.69
-11.6%
9.2%US$14.00US$11.00US$9.924
May ’22US$13.14
US$12.06
-8.2%
5.2%US$12.50US$11.00US$10.024
Apr ’22US$12.82
US$11.81
-7.9%
5.9%US$12.50US$11.00US$12.114
Mar ’22US$11.76
US$11.31
-3.8%
6.5%US$12.50US$10.50US$11.924
Feb ’22US$10.34
US$10.75
+4.0%
2.3%US$11.00US$10.50US$14.294
Jan ’22US$10.25
US$10.50
+2.4%
3.4%US$11.00US$10.00US$15.084
Dec ’21US$10.30
US$10.00
-2.9%
7.9%US$11.00US$9.00US$15.624
Nov ’21US$8.35
US$9.13
+9.3%
8.1%US$10.00US$8.00US$15.804

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies